Navigation Links
Scientists, policymakers and industry leaders gather to discuss ocean iron fertilization
Date:9/25/2007

On September 26-27, scientists at the Woods Hole Oceanographic Institution (WHOI) will host an international, interdisciplinary conference on the proposed iron fertilization of the ocean as a means to combat rising concentrations of greenhouse gases in the atmosphere.

Several times over the past century, scientists and environmental engineers have proposed spreading slurries of dissolved iron into the oceans in order to fertilize the waters and promote vast blooms of marine plants (phytoplankton). Phytoplankton consume carbon dioxide as they grow, and this growth can be stimulated in certain ocean basins by the addition of iron, a necessary micronutrient.

Though common on land, dissolved iron is often rare in the ocean. Some researchers and commercial interests have recently proposed to provide that missing nutrient on a large scale in order to create artificial blooms. Theory holds that if you make such blooms large enough, you could remove excess carbon dioxide from Earths atmosphere and carry it down into the deep ocean as organic matter (such as fecal pellets and dead plankton) sinks, thereby reducing the impact of greenhouse gases and global warming.

There are many critical questions that require both better scientific understanding and an improved legal, economic, and political framework before iron fertilization can be considered either effective or appropriate, said Ken Buesseler, a senior scientist in WHOIs Marine Chemistry and Geochemistry Department and a participant in two iron fertilization experiments at sea. The time is right to bring scientists, policymakers, and commercial interests together to inform each other and the public.

Scientists took a serious interest in the idea in the late 1980s after oceanographer John Martin famously told colleagues: Give me half a tanker of iron and Ill give you the next ice age. Iron fertilization has since been tested in at least a dozen experiments around the world. The
'/>"/>

Contact: WHOI Media Relations
media@whoi.edu
508-289-3340
Woods Hole Oceanographic Institution
Source:Eurekalert

Page: 1 2

Related biology news :

1. For Stanford scientists, RNAi gene therapy takes two steps forward, one step back
2. Affymetrix and ParAllele Launch Industrys Most Comprehensive Product Line for Targeted Genotyping
3. Shark skin saves naval industry money
4. Quick identification needed to save Floridas citrus industry from devastating disease
5. Scaled-down genome may power up E. colis ability in lab, industry
6. Report finds cruise industry is protecting the precious places it visits
7. Over-use of antibiotics in fish-for-food industry encourages bacterial resistance and disease
8. A cleaner, greener rice industry
9. Protect patients from exploitation by alternative medicines industry
10. Developing uses for sugar-cane bagasse: Biotechnology applied to the paper industry
11. Plastic that degrades in seawater could be boon for cruise industry and others

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...t Norman has received more than $10 million in res... the federal stimulus program, bringing thetotal a...rs to $23 million. Thirty-three projects achieved...logy to weather. , "The university has thoughtfu...reasof scholarly excellence to federal agency prio...
(Date:11/4/2009)...PRNewswire-FirstCall/ -- Quest Diagnostics Incorpo...of diagnostic testing, information and services, a...r 30, 2009, income from continuing operations rose... $160 million, or $0.81 per diluted share, for the...ults were reduced by a $0.03 per share charge asso...
(Date:11/4/2009)... Aware, Inc. (Nasdaq: AW...nd biometrics software, today reported financial r...2009. ,, Michael Tzannes, Aware,s Chairman an...e announced an agreement to sell our DSL and home ...semiconductor company being spun out of Infineon. ...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 1Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 2Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 3EGEN Inc Announces the Promotion of Jason Fewell Ph D to Vice President of Preclinical Research and Development 13448 1EGEN Inc Announces the Promotion of Jason Fewell Ph D to Vice President of Preclinical Research and Development 13448 2NeurogesX Reports Second Quarter 2009 Results 13446 1NeurogesX Reports Second Quarter 2009 Results 13446 2NeurogesX Reports Second Quarter 2009 Results 13446 3NeurogesX Reports Second Quarter 2009 Results 13446 4NeurogesX Reports Second Quarter 2009 Results 13446 5NeurogesX Reports Second Quarter 2009 Results 13446 6NeurogesX Reports Second Quarter 2009 Results 13446 7NeurogesX Reports Second Quarter 2009 Results 13446 8NeurogesX Reports Second Quarter 2009 Results 13446 9NeurogesX Reports Second Quarter 2009 Results 13446 10NeurogesX Reports Second Quarter 2009 Results 13446 11NeurogesX Reports Second Quarter 2009 Results 13446 12
...rrow Neurological Institute at St. Joseph,s Hospit...k between eye motions and the perception of illuso...Stephen Macknik, PhD, director of the Laboratory o...e, PhD, director of the Laboratory of Visual Neuro...illan; conducted a study based on the Enigma paint...
... have grown soybeans and turned them into many use...hy a soybean grows, blooms or produces like it doe... , University of Georgia professor Wayne Parrott...million grant from the National Science Foundation...ue. , "I,m convinced that soybeans would be so mu...
... city dwellers posed by Southern California wildfi...restimated by officials. , Detailed particulate a...ia wild fires indicates that the composition posed...generally realized, according to a new paper analy...thern California. , The paper, entitled "Physico...
Other Biology News:Soybean grant gives researchers tools to unravel better bean 2Where there's wildfire smoke, there's toxicity 2
(Date:11/9/2009)...re-USNewswire/ -- The Appignani Bioethics Center, ...ld a panel discussion today at the National Press ...s in biomedical sciences and climate change. The t...ght, both of the Center for American Progress, who...angles. ,, A video of the event will be made a...
(Date:11/9/2009)...ire-Asia-FirstCall/ -- Yongye International, Inc.,...ding manufacturer, developer,and distributor of Sh... in the,People,s Republic of China (PRC), today an...10:00 a.m. Eastern Time (11:00 p.m. Beijing Time) ...r the quarter ended September 30, 2009. , ...
(Date:11/9/2009)...vember 9 For more than 20 years,re...the development of a,Brain-Computer Interface (BCI...the brain and a computer. Such a system enables co...ontrol devices in their environment just by,mental...e been supervised by,the researchers themselves to...
(Date:11/9/2009)...e/ -- NexBio, Inc. announced the presentation of n...ergy, Asthma, and Immunology in Miami, Florida. T...;), a Sialidase, Decreases Airway Resistance and H...ls of Asthma". ,, DAS181 (Fludase ® ) is a...ug candidate being studied in human clinical devel...
Breaking Biology Technology:Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 3Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 3intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3
...ed for the First Time on 50 mg/Day Dose for PRISTI...ssive Disorder, COLLEGEVILLE, Pa., Dec. 12 Wyeth...), announces that data from,two Phase 3 clinical s...gational serotonin-norepinephrine reuptake inhibit... a 50 mg/day dose of PRISTIQ for the,treatment of ...
...he Netherlands, December 12 , - Forty-five Presti...Response to Customer Demand, Elsevier, a leading ...M) information, today announced that 45 French-lan...e available on ScienceDirect beginning January,3, ...gie, Journal de Chirurgie and,La Press Medicale, r...
...IND has Been Filed With the FDA for the Fourth Gen...Collaboration with Roche., COPENHAGEN, December 1...nvestigational New Drug application (IND) for a,Ge...oration with Roche has,been filed with the FDA by ...velopment of the antibody which selectively blocks...
Other Biology Technology:New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 2New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 3New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 4New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 5New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 6ScienceDirect to Host French-Language Journals from Elsevier Masson 2ScienceDirect to Host French-Language Journals from Elsevier Masson 3Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic 2Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic 3
...ade; is a recombinant preparation of the catalytic...Enterokinase is expressed and isolated from the ye...yme preparation (2). It recognizes the sequence As...er the lysine residue. The enzyme can be used to c...
...in U-23 (rat) - Diluted Antiserum for RIA, Host: R... Products, Host: Rabbit Antigen sequence: H-Tyr-...y-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH 2 For ou...ptide, please see Neuromedin U-23 (rat) (H-9295) a...
Mae II from Roche Applied Science
Xho I from Roche Applied Science
Biology Products: